Ambuja Cements Past Earnings Performance
Past criteria checks 4/6
Ambuja Cements has been growing earnings at an average annual rate of 10%, while the Basic Materials industry saw earnings growing at 1.9% annually. Revenues have been growing at an average rate of 6.8% per year. Ambuja Cements's return on equity is 8.1%, and it has net margins of 11.9%.
Key information
10.00%
Earnings growth rate
6.94%
EPS growth rate
Basic Materials Industry Growth | 2.92% |
Revenue growth rate | 6.78% |
Return on equity | 8.08% |
Net Margin | 11.89% |
Last Earnings Update | 31 Mar 2025 |
Recent past performance updates
There May Be Underlying Issues With The Quality Of Ambuja Cements' (NSE:AMBUJACEM) Earnings
May 10We Think That There Are Issues Underlying Ambuja Cements' (NSE:AMBUJACEM) Earnings
Nov 08Recent updates
There May Be Underlying Issues With The Quality Of Ambuja Cements' (NSE:AMBUJACEM) Earnings
May 10Ambuja Cements (NSE:AMBUJACEM) Is Paying Out A Dividend Of ₹2.00
May 02With EPS Growth And More, Ambuja Cements (NSE:AMBUJACEM) Makes An Interesting Case
Apr 28Investors Could Be Concerned With Ambuja Cements' (NSE:AMBUJACEM) Returns On Capital
Feb 21Ambuja Cements Limited's (NSE:AMBUJACEM) Share Price Not Quite Adding Up
Jan 19These 4 Measures Indicate That Ambuja Cements (NSE:AMBUJACEM) Is Using Debt Reasonably Well
Dec 14We Think That There Are Issues Underlying Ambuja Cements' (NSE:AMBUJACEM) Earnings
Nov 08Calculating The Fair Value Of Ambuja Cements Limited (NSE:AMBUJACEM)
Oct 31Some Shareholders Feeling Restless Over Ambuja Cements Limited's (NSE:AMBUJACEM) P/E Ratio
Oct 11Ambuja Cements (NSE:AMBUJACEM) May Have Issues Allocating Its Capital
Sep 14Here's Why Ambuja Cements (NSE:AMBUJACEM) Can Manage Its Debt Responsibly
Jul 23Returns On Capital At Ambuja Cements (NSE:AMBUJACEM) Have Stalled
May 30Revenue & Expenses Breakdown
How Ambuja Cements makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 25 | 350,448 | 41,674 | 97,046 | 0 |
31 Dec 24 | 340,501 | 42,651 | 98,500 | 0 |
30 Sep 24 | 328,504 | 29,740 | 96,129 | 0 |
30 Jun 24 | 327,582 | 33,175 | 95,807 | 0 |
31 Mar 24 | 331,596 | 35,768 | 97,572 | 0 |
31 Dec 23 | 322,316 | 31,666 | 97,440 | 0 |
30 Sep 23 | 320,096 | 27,779 | 97,601 | 0 |
30 Jun 23 | 317,170 | 20,781 | 98,087 | 0 |
31 Mar 23 | 310,370 | 19,245 | 95,875 | 0 |
31 Dec 22 | 309,828 | 19,385 | 90,306 | 0 |
30 Sep 22 | 307,014 | 17,947 | 93,696 | 0 |
30 Jun 22 | 302,053 | 23,673 | 92,252 | 0 |
31 Mar 22 | 291,507 | 24,920 | 89,400 | 0 |
31 Dec 21 | 289,655 | 27,804 | 90,163 | 0 |
30 Sep 21 | 287,931 | 32,220 | 90,671 | 0 |
30 Jun 21 | 283,154 | 31,780 | 89,981 | 0 |
31 Mar 21 | 259,813 | 27,584 | 83,538 | 0 |
31 Dec 20 | 245,162 | 23,654 | 80,836 | 0 |
30 Sep 20 | 241,848 | 22,247 | 81,813 | 0 |
30 Jun 20 | 240,926 | 19,880 | 82,843 | 0 |
31 Mar 20 | 265,225 | 21,538 | 89,045 | 0 |
31 Dec 19 | 271,036 | 20,950 | 90,924 | 0 |
30 Sep 19 | 267,058 | 24,778 | 91,030 | 0 |
30 Jun 19 | 266,458 | 23,804 | 91,111 | 0 |
31 Mar 19 | 264,121 | 22,830 | 92,072 | 0 |
31 Dec 18 | 260,409 | 21,774 | 91,194 | 0 |
30 Sep 18 | 254,518 | 16,121 | 88,956 | 0 |
30 Jun 18 | 248,200 | 15,850 | 86,285 | 0 |
31 Mar 18 | 243,478 | 16,147 | 69,353 | 0 |
31 Dec 17 | 235,855 | 15,164 | 81,745 | 0 |
30 Sep 17 | 224,324 | 13,481 | 75,217 | 0 |
30 Jun 17 | 215,147 | 12,769 | 72,476 | 0 |
31 Mar 17 | 206,207 | 12,409 | 68,960 | 0 |
31 Dec 16 | 201,319 | 11,051 | 68,209 | 0 |
30 Sep 16 | 177,442 | 10,265 | 54,848 | 0 |
31 Dec 15 | 94,330 | 8,079 | 32,249 | 0 |
31 Dec 14 | 99,606 | 14,865 | 31,499 | 0 |
Quality Earnings: AMBUJACEM has a high level of non-cash earnings.
Growing Profit Margin: AMBUJACEM's current net profit margins (11.9%) are higher than last year (10.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AMBUJACEM's earnings have grown by 10% per year over the past 5 years.
Accelerating Growth: AMBUJACEM's earnings growth over the past year (16.5%) exceeds its 5-year average (10% per year).
Earnings vs Industry: AMBUJACEM earnings growth over the past year (16.5%) exceeded the Basic Materials industry -24.3%.
Return on Equity
High ROE: AMBUJACEM's Return on Equity (8.1%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/05/28 19:19 |
End of Day Share Price | 2025/05/28 00:00 |
Earnings | 2025/03/31 |
Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ambuja Cements Limited is covered by 77 analysts. 32 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Satyadeep Jain | Ambit Capital |
Nitin Bhasin | Ambit Capital |
null null | Anand Rathi Shares and Stock Brokers Limited |